AAV9-derived peptides grafted onto nanoparticles, combined with electroporation, synergistically enhance drug transport across the blood-brain barrier.
Synergistic BBB crossingPeptide-coated nanoparticles + electroporation exceeded either approach alone for brain penetration
What the researchers found
AAV9-derived peptides (AAV.PHP.eB, AAV.X1, AAV.CPP.16) grafted onto nanoparticles synergized with electroporation to enhance BBB transport beyond either approach alone.
Why it matters
Brain diseases like Alzheimer's and brain cancers lack effective treatments partly because drugs can't cross the BBB. This dual approach could enable delivery of life-saving therapies.
How the study worked
Nanoparticle engineering with AAV9-based surface peptides combined with electroporation, testing BBB transport efficiency in models.
What this study cannot tell us
Preclinical study — in vivo brain penetration and drug delivery efficacy in disease models not yet demonstrated. Electroporation may have safety concerns.
How to read the evidence
Preclinical proof-of-concept study — demonstrates a novel combination strategy for BBB crossing.
When this study was published
Published in 2026; uses cutting-edge peptide and nanoparticle technology.
The bigger picture
Combining bio-inspired peptide targeting with physical barrier disruption represents a powerful general strategy for brain drug delivery.
Questions still open
- Can this approach deliver therapeutic doses of drugs to specific brain regions?
- Is repeated electroporation safe for chronic brain disease treatment?
Common questions
Why is the blood-brain barrier a problem for drugs?
How do virus peptides help drugs enter the brain?
Read the original research
AAV9-Mimetic Peptides and Electroporation Synergistically Enhance Nanoparticle Transport through the Blood-Brain Barrier.
ACS biomaterials science & engineering
Citation
Butkovich, Nina; Xu, Yifei; Song, Yuchen; Wang, Lu; Ramirez, Aaron; Li, Enya; Siao, Nikhil Tien Chi; Velazquez-Rivera, Eric; Xiang, Liangzhong; Xu, Xiangmin; Wang, Szu-Wen. (2026). AAV9-Mimetic Peptides and Electroporation Synergistically Enhance Nanoparticle Transport through the Blood-Brain Barrier.. ACS biomaterials science & engineering. https://doi.org/10.1021/acsbiomaterials.5c01483